uniQure N.V. (QURE) is a publicly traded Healthcare sector company. As of November 19, 2026, QURE trades at $20.17 with a market cap of $1.42B and a P/E ratio of -5.50. QURE moved -1.58% today. Year to date, QURE is -10.24%; over the trailing twelve months it is -31.63%. Its 52-week range spans $7.76 to $71.50. Analyst consensus is strong buy with an average price target of $54.29. Rallies surfaces QURE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for QURE shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $20.17 |
| Market Cap | $1.42B |
| P/E Ratio | -5.50 |
| EPS | $-4.03 |
| Dividend Yield | 0.00% |
| 52-Week High | $71.50 |
| 52-Week Low | $7.76 |
| Volume | 627.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $18.67M |
| Net Income | $-252.21M |
| Gross Margin | 92.49% |
10 analysts cover QURE: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $54.29.